Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-649-0 | CAS number: 72403-66-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From 22 July 1994 to 24 January 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5300 (Detection of Gene Mutations in Somatic Cells in Culture)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EEC Directive 87/302, Annex (November 18, 1987) Part B; Mutagenicity testing and screening for carcinogenicity; In vitro mammalian cell gene mutation test.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- EC Number:
- 276-649-0
- EC Name:
- Disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Cas Number:
- 72403-66-8
- Molecular formula:
- C36H21ClCrN7Na2O12S
- IUPAC Name:
- disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Test material form:
- other: solid
Constituent 1
Method
- Target gene:
- hypoxanthine-guanine phosphoribosyl transferase (hprt)
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Ham's F 10 medium supplemented with 10% foetal calf serum and antibiotics
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat-liver post mitochondrial supernatant (S9 fraction)
- Test concentrations with justification for top dose:
- CYTOXICITY TEST
Range with metabolic activation:
500.0000 µg/ml
250.0000 µg/ml
125.0000 µg/ml
62.5000 µg/ml
31.2500 µg/ml
15.6250 µg/ml
7.8125 µg/ml
3.9063 µg/ml
1. 9531 µg/ml
0.9766 µg/ml
0.4883 µg/ml
0.2441 µg/ml
Range without metabolic activation:
500.0000 µg/ml
250.0000 µg/ml
125.0000 µg/ml
62.5000 µg/ml
31.2500 µg/ml
15.6250 µg/ml
7.8125 µg/ml
3.9063 µg/ml
1. 9531 µg/ml
0.9766 µg/ml
0.4883 µg/ml
0.2441 µg/ml
MUTAGENICITY TEST
Original experiment:
Range with metabolic activation:l
250.0000 µg/ml
83.3333 µg/ml
27.7778 µg/ml
9.2593 µg/ml
Range without metabolic activation:
100.0000 µg/ml
33.3333 µg/ml
11.1111 µg/ml
3.7037 µg/ml
Confirmatory experiment:
Range with metabolic activation:
300.0000 µg/ml
100.0000 µg/ml
33.3333 µg/ml
11.1111 µg/ml
Range without metabolic activation:
150.0000 µg/ml
50.0000 µg/ml
16.6667 µg/ml
5.5556 µg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle:
Controls
- Untreated negative controls:
- yes
- Remarks:
- DMSO
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-dimethylnitrosamine
- ethylmethanesulphonate
- Remarks:
- N-dimethylnitrosamine with metabolic activation; ethylmethanesulphonate without metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: in the experiments with metabolic activation for 5 hours and in the experiments without metabolic activation for 21 hours
- Expression time (cells in growth medium): from 7 to 8 days
SELECTION AGENT (mutation assays):
- 6-thioguanine
NUMBER OF REPLICATIONS:
- cultures were treated in duplicate with four test chemical concentrations, a positive and a negative control
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- All mutant frequencies are normalized to a virtual cloning efficiency of 100% at the end of the expression period. If the cloning efficiency of the viability cultures is lower than 15%, the corresponding mutant frequency is usually not calculated, owing to the high statistical insignificance of the result. For every concentration a mean mutant factor, which is defined as the ratio of the mean mutant frequencies of the treated cultures with the mean mutant frequencies of the solvent control cultures, will be calculated.
- Statistics:
- Statistical significance of mutant frequencies was carried out according to the UKEMS guidelines: ARLETT, C.F., D.M. SMITH, M.H.L. Green, D.B. McGREGOR, G.M. CLARKE, J. COLE, J.C. ASQUITH (1990) Mammalian cell gene mutation assays based upon colony formation. In: Statistical Evaluation of Mutagenicity Test Data (ed Kirkland, D.J.) Cambridge University press, pp 67-101.
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not applicable
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
In the preliminary toxicity test with and without metabolic activation 12 concentrations of substance were tested. The concentrations selected ranged from 0.24 to 500.0 µg/ml and separated by 2-fold intervals.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
No toxicity was seen during original experiment performed with and without metabolic activation.
No toxicity was seen during confirmatory experiment performed with and without metabolic activation. - Remarks on result:
- other: strain/cell type: Chinese Hamster cell line V79
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Non mutagenic
- Executive summary:
Method
The experiment was conducted in agreement to OECD Guideline 476 (In vitro Mammalian Cell Gene Mutation Test), EPA OTS 798.5300 (Detection of Gene Mutations in Somatic Cells in Culture) and EEC Directive 87/302, Annex (November 18, 1987) Part B ( Mutagenicity testing and screening for carcinogenicity; In vitro mammalian cell gene mutation test).
The test was performed following the GLP.
The test article was tested for mutagenic effects on V79 Chinese hamster cells in vitro. The test substance was dissolved in DMSO.
A preliminary range finding test was run assessing cytotoxicity. The substance was tested at concentrations up to 500.0 µg/ml. Higher concentration could not be applied due to solubility limitations in the vehicle. The cultures were exposed to the test substance for five hours in the presence and for 21 hours in the absence of a metabolic activation system. In the two parts of the experiment, 12 concentrations of the test substance and two vehicle (DMSO) controls were tested. Compound-induced cytotoxicity was estimated by cloning efficiency immediately after treatment.
Depending on the toxicity of the test compound 2.5-5.0x10E6 cells of passage 27 (original experiment) and passage 31 (confirmatory experiment) were plated in 30 ml growth medium into flasks and incubated overnight. The growth medium was replaced for five hours by 27 ml treatment medium and 3.0 ml S9 activation mixture, or for 21 hours by 30 ml treatment medium alone.
In each assay, cultures were treated in duplicate with four test chemical concentrations, a positive and a negative (DMSO) control. In the non-activated part of the experiment, the positive control was the ultimate mutagen Ethylmethansulphonate (EMS) at a concentration of 0.3 µl/ml. In the part with metabolic activation the positive control was the promutagen N-Nitrosodimethylamine (DMN) at a concentration of 1.0 µl/ml.
Cytotoxicity of the compound was estimated from the cloning efficiency immediately after treatment. The number of colonies which developed within seven to eight days in these cultures reflected the viability at the end of the treatment (survival values).
The cultures were incubated at 37°C for seven to eight days during which the cells could recover and divide to express the mutant phenotype. At the end of the expression period the cultures were trypsinised pelleted, resuspended in fresh growth medium and counted.
The high-density cultures were subjected to the mutant selection procedure by supplementing the growth medium with 8 µg/ml 6-thioguanine (6-TG). Only cells mutated at the hprt locus could survive the 6-thioguanine treatment. The number of colonies formed in these flasks during the following days reflected the overall number of mutations induced by the treatment with the test substance or the mutagen (positive control).
After seven to eight days incubation at 37°C, the cultures were fixed and stained with Giemsa. The mutant clones were counted with the naked eye.
In parallel the viability at the end of the expression period was estimated from the cloning efficiency. The number of colonies which developed within these cultures reflected the viability at the end ofthe expression period (viability values).
Results
According to the acceptance criteria outlined in the above mentioned guidelines, in the presence and absence of metabolic activation, no relevant increase in mutant frequency was observed at any concentration level of substance tested in the original or the confirmatory experiment in comparison with the negative control.
In the two experiments performed in the presence of metabolic activation, statistically significant differences were obtained at two concentrations each. However, at none of these concentrations the number of normalized mutant clones differed by more than 20 compared to the respective control cultures.
Moreover, no concentration dependency was obvious and the effects were not reproducible (appeared at different concentrations in the two experiments). They are therefore considered to be purely fortuitous and not related to treatment with the test compound.
The positive controls induced a clear increase in mutant frequency.
Conclusion
Non mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.